GV350 High-Voltage Pulsed Current for Edema: How HVPS Fits Into Swelling Management

GV350 High-Voltage Pulsed Current for Edema: How HVPS Fits Into Swelling Management

Can the BioMedical Life Systems GV350 High Volt Pulsed Stimulator be used when edema—or swelling—is part of the rehabilitation problem?

Potentially, yes, under professional direction.

BioMedical Life Systems currently identifies edema reduction among the applications for the GV350. The device delivers high-voltage pulsed stimulation (HVPS), commonly called high-voltage pulsed current (HVPC) in the rehabilitation literature.

But HVPC for edema is more nuanced than simply placing electrodes over a swollen area.

The clinical literature includes:

• promising basic-science studies of acute post-traumatic edema;
• older human studies with mixed results;
• polarity-specific research;
• treatment protocols that used pulse rates the GV350 cannot exactly reproduce; and
• different edema mechanisms that may be better addressed by muscle-pump NMES, compression, exercise, or medical treatment.

The most useful way to think about the GV350 is

HVPC is one clinician-directed tool that may be incorporated into edema management when the cause of the swelling, treatment objective, electrode configuration and device precautions have first been established.

The GV350 is not a substitute for diagnosing unexplained swelling.

For specifications and current availability, see BioMedical Life Systems GV350 High Volt Pulsed Stimulator.

Can the GV350 Be Used for Edema? Quick Answer

The GV350 is a prescription high-voltage pulsed stimulator with selectable positive/negative active polarity, a 1–100 Hz pulse-rate range, two active outputs, and a larger dispersive return electrode.

What Is Edema?

Edema is an abnormal accumulation of fluid within tissues.

It is a sign, not a diagnosis.

Swelling may occur because of:

• acute musculoskeletal injury;
• surgery;
• immobility;
• impaired venous return;
• lymphatic dysfunction;
• inflammation;
• infection;
• medication effects;
• heart, kidney, or liver disease; or
• a vascular problem such as deep-vein thrombosis.

That distinction matters because a modality appropriate for one type of swelling may be inappropriate for another.

A swollen ankle after a carefully evaluated musculoskeletal injury is not clinically equivalent to:

• unexplained one-sided calf swelling;
• cellulitis;
• thrombophlebitis;
• decompensated heart failure;
• chronic lymphedema; or
• postoperative swelling before surgical clearance.

Before choosing electrical stimulation, establish why the edema is present.

What Is High-Voltage Pulsed Current?

HVPC is a form of pulsed electrical stimulation characterized by:

• very brief high-voltage pulses;
• low overall average current;
• a monophasic waveform;
• selectable active-electrode polarity; and
• the ability to work at sensory, submotor, or motor-level intensities depending on the clinical objective.

The GV350 uses a twin-peak monophasic waveform and provides:

• selectable positive or negative active polarity;
• 1–100 Hz pulse rate;
• continuous or alternating operation;
• two active-electrode outputs;
• a larger dispersive return electrode; and
• 15-, 30-, or 60-minute timer selections.

Those features distinguish it from conventional biphasic NMES systems.

HVPC for Edema Is Not the Same as NMES for Edema

This distinction is important for Balego because the two modalities can address swelling through different treatment strategies.

HVPC strategy

Traditional HVPC edema research has often examined sensory or submotor stimulation, particularly during acute post-traumatic swelling.

The treatment concept is not necessarily to create a large muscle contraction.

NMES muscle-pump strategy

Conventional NMES can intentionally create repeated muscular contractions.

Those contractions can act as a muscle pump, helping move venous and lymphatic fluid proximally when that strategy is clinically appropriate.

HVPC vs. NMES for swelling

If the clinical objective is specifically to generate repeated calf, quadriceps, or another muscle-pump contraction, we already covers that separately in NMES for Edema Reduction: Settings, Electrode Placement, Evidence & Safety.

The Balego EMS Digital BAL805 NMES Stimulator is better suited to that conventional contraction/rest workflow.

What Does the Research Say About HVPC for Edema?

The answer is promising in some settings but mixed overall.

That is more accurate than saying either:

“HVPC is proven to eliminate edema."

or

“HVPC does not work.”

The result depends heavily on:

• edema mechanism;
• injury timing;
• polarity;
• pulse frequency;
• electrode configuration;
• treatment duration; and
• whether the evidence comes from animal or human research.

Why Negative-Polarity HVPC Is Frequently Mentioned

Much of the classic acute-edema literature investigated negative-polarity—cathodal—HVPC.

A systematic review of the basic-science literature found that the most consistently favorable experimental approach used approximately:

• negative polarity;
• 120 pulses per second;
• intensity near but below visible motor contraction; and
• relatively long or repeated treatment exposure.

The authors concluded that this protocol appeared capable of limiting acute edema formation in the experimental literature.

But there is a major limitation:

Much of that evidence came from animal/basic-science models rather than direct human clinical trials.

It is useful for understanding why negative-polarity HVPC became associated with acute edema management.

It is not a universal prescription for every swollen patient.

The GV350 Cannot Exactly Reproduce the Classic 120-PPS Edema Protocol

This is one of the most important practical details for anyone trying to translate the literature to this particular device.

The GV350 provides a pulse-rate range of

1–100 Hz.

A number of influential acute-edema experiments used:

120 pulses per second.

Therefore:

The classic 120-pps protocol cannot be copied exactly onto a GV350.

Do not turn that into:

“Just use 100 Hz because it is close enough.”

No evidence establishes that 100 Hz on the GV350 is clinically equivalent to the classic 120-pps experimental protocol.

In fact, a later animal study using negative-polarity HVPC at 100 Hz did not demonstrate significant edema or pain reduction compared with sham treatment in that model.

That makes device-specific clinical judgment more important, not less.

Classic HVPC Edema Research vs. What the GV350 Can Deliver

This table is why a product-specific article is more useful than simply reposting an old HVPC textbook protocol.

What Did Human Ankle-Sprain Research Find?

The human evidence is less convincing than the early experimental literature.

A randomized trial involving patients with acute lateral ankle sprains compared conventional treatment with positive- or negative-polarity HVPC.

The study did not find statistically significant differences between the groups in the main edema and recovery outcomes.

The negative-polarity group showed some numerically favorable changes, but those findings did not establish a clear treatment advantage.

A later systematic review examining electrical stimulation for acute lateral ankle sprains similarly concluded that the available trials did not provide sufficient evidence to recommend electrical stimulation for reducing edema, pain, or improving function in that condition.

Practical takeaway

HVPC should not be presented as:

"The proven treatment for ankle-sprain swelling.”

A more accurate statement is

HVPC has a plausible experimental basis and some suggestive clinical findings, but human evidence for acute ankle-sprain edema remains inconsistent.

What About Chronic Hand or Post-Traumatic Edema?

HVPC has also been studied in persistent hand edema.

Older human studies produced mixed results.

One randomized study comparing intermittent pneumatic compression, HVPC, and placebo HVPC found a clear effect for pneumatic compression, while the HVPC comparison did not reach statistical significance.

A later larger study of chronic hand and wrist edema reported reductions in edema and pain within the energized HVPC treatment group, providing some supportive evidence, although the overall literature remains limited.

The appropriate conclusion is not that HVPC is ineffective.

It is that:

The evidence base is relatively small, older, and heterogeneous, and the strongest treatment choice depends on the type of edema.

How Might HVPC Influence Acute Edema?

The exact mechanism is not completely established.

One proposed explanation is that HVPC may influence microvascular permeability and macromolecular leakage during acute tissue injury.

In simple terms, acute inflammation can allow plasma proteins and fluid to move from the microcirculation into surrounding tissue.

Experimental HVPC research has examined whether electrical stimulation can alter that leakage and thereby limit the formation of additional edema.

That mechanism remains an area of research rather than a settled clinical fact. Studies evaluating related vascular mechanisms have produced mixed findings.

Therefore, avoid describing HVPC as if it:

• “electrically pushes water out”;
• “drains lymph through the skin”; or
• “repels swelling.”

Those phrases oversimplify the physiology.

Does the GV350 Need to Produce a Muscle Contraction for Edema?

Not necessarily.

This is another way HVPC edema treatment differs from conventional NMES edema treatment.

Many classic acute-edema HVPC experiments used intensity below visible motor contraction.

That means the intended treatment mechanism was not simply:

muscle contracts → veins are squeezed → fluid moves proximally.

By contrast, when NMES is deliberately used as a muscle pump, visible rhythmic contraction is normally the treatment objective.

Choose the strategy according to the clinical goal.

Should the GV350 Always Be Set to Negative Polarity for Edema?

No universal rule should be published that way.

Negative polarity is prominent in the classic acute post-traumatic edema literature.

But that does not mean:

negative = every edema condition

or

positive = wrong.

Polarity can depend on:

• treatment objective;
• pathology;
• stage of healing;
• electrode location;
• whether wound-care goals are involved; and
• the specific clinical protocol.

BioMedical Life Systems itself publishes HVPS protocols using different polarity choices for different clinical situations, reinforcing that polarity should be selected according to the therapeutic objective rather than a one-line internet rule.

The GV350 provides both positive and negative active polarity precisely because polarity is a treatment variable.

Why We Are Not Publishing a Universal “GV350 Edema Setting”

A responsible GV350 edema article should not tell every reader:

Set negative polarity, 100 Hz, turn it up to X, and place the pad over the swelling.

There are several reasons.

1. The evidence does not support one universal protocol.

Research differs by:

• acute vs. chronic edema;
• animal vs. human study;
• electrode type;
• frequency;
• polarity;
• duration; and
• injury model.

2. The classic research often used 120 pps.

The GV350 only reaches 100 Hz.

3. The manufacturer's manual contains important placement precautions.

The current GV350 manual hosted by BioMedical Life Systems warns against HVPC use over swollen, infected, or inflamed areas and specifically references vascular conditions, including phlebitis, thrombophlebitis, and varicose veins.

4. Edema can signal a serious condition.

A treatment recipe cannot safely distinguish a sprained ankle from a DVT.

5. The GV350 is prescription-only.

Treatment settings and electrode location should follow the prescribing clinician and current device instructions.

“Edema Reduction” Does Not Mean “Put the Pad on Any Swollen Area”

BioMedical Life Systems currently markets the GV350 for uses that include edema reduction.

At the same time, its GV350 manual warns against using HVPC over swollen, infected, or inflamed regions and over certain vascular problems.

Those statements are a reason for more clinical specificity, not less.

They should not be resolved by assuming either:

• Every edema application is prohibited; or
• Every swollen area is an acceptable electrode site.

Instead:

When edema reduction is the therapeutic objective, the treating professional should confirm the cause of the edema, current manufacturer guidance, electrode field and treatment protocol before applying the GV350.

That is a materially safer interpretation than copying an electrode diagram from an unrelated HVPC study.

The GV350 Uses Active Electrodes Plus a Larger Dispersive Return

The GV350's electrode configuration is another reason it should not be treated like an ordinary two-pad TENS unit.

The system includes:

• two smaller active-electrode outputs; and
• a larger dispersive return electrode.

The manufacturer provides one large 4 × 7-inch dispersive electrode with the system, along with smaller active electrodes.

The larger return helps distribute current over a broader area.

The selected active polarity applies to the active electrode circuit and is one of the variables used in HVPC treatment.

Why this matters

Research results have varied with:

• electrode placement;
• electrode geometry;
• surface versus other electrode configurations; and
• polarity.

One experimental study found that changing to